Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Myositis

Prognostic factors in 'pneumo-myositis'

Nature Reviews Rheumatology volume 14, pages 253–254 (2018)Cite this article

Subjects

Interstitial lung disease (ILD) is a major cause of death and disability in patients with polymyositis or dermatomyositis. To begin to improve patient outcomes, the clinical, demographic and therapeutic factors associated with poor prognosis for patients with ILD associated with polymyositis or dermatomyositis need to be identified.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Typical presentation of 'pneumo-myositis' with lung, muscle and skin involvement.

References

  1. Johnson, C. et al. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194, 733–737 (2016).

    Article  CAS  Google Scholar 

  2. Johnson, C. et al. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type. Respir. Med. 108, 1542–1548 (2014).

    Article  CAS  Google Scholar 

  3. Chua, F. et al. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort. Rheumatology 51, 1870–1876 (2012).

    Article  Google Scholar 

  4. Pinal-Fernandez, I. et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology 56, 999–1007 (2017).

    Article  CAS  Google Scholar 

  5. Sugiyama, Y. et al. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Res. Ther. 20, 7 (2018).

    Article  Google Scholar 

  6. Mecoli, C. A. et al. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin. Exp. Rheumatol. 35, 671–673 (2017).

    PubMed  Google Scholar 

  7. Fischer, A. et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur. Respir. J. 4, 976–987 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

The work of S.K.D. is supported financially by the Huayi and Siuling Zhang Fund for Myositis.

Author information

Authors and Affiliations

  1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Sonye K. Danoff

Authors
  1. Sonye K. Danoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sonye K. Danoff.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Danoff, S. Prognostic factors in 'pneumo-myositis'. Nat Rev Rheumatol 14, 253–254 (2018). https://doi.org/10.1038/nrrheum.2018.55

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2018.55

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing